FRANKLIN RESOURCES INC - CONCERT PHARMACEUTICALS INC ownership

CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 97 filers reported holding CONCERT PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.14 and the average weighting 0.1%.

Quarter-by-quarter ownership
FRANKLIN RESOURCES INC ownership history of CONCERT PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$201,000
-31.9%
30,000
-57.1%
0.00%
Q2 2022$295,000
-95.8%
70,000
-87.4%
0.00%
-100.0%
Q4 2018$6,985,000
-15.5%
556,600
-0.0%
0.00%0.0%
Q3 2018$8,262,000
-14.9%
556,762
-3.5%
0.00%
-20.0%
Q2 2018$9,711,000
-26.5%
577,035
+0.0%
0.01%
-28.6%
Q1 2018$13,211,000
-15.3%
576,900
-4.3%
0.01%0.0%
Q4 2017$15,589,000
+53.8%
602,600
-12.3%
0.01%
+40.0%
Q3 2017$10,133,000
+5.7%
687,0000.0%0.01%0.0%
Q2 2017$9,584,000
-18.2%
687,0000.0%0.01%
-16.7%
Q1 2017$11,720,000
+65.8%
687,0000.0%0.01%
+50.0%
Q4 2016$7,069,000
+1.8%
687,0000.0%0.00%0.0%
Q3 2016$6,946,000
-10.0%
687,0000.0%0.00%0.0%
Q2 2016$7,715,000
-17.8%
687,0000.0%0.00%
-20.0%
Q1 2016$9,384,000
-28.0%
687,0000.0%0.01%
-28.6%
Q4 2015$13,032,000
+1.1%
687,0000.0%0.01%
+16.7%
Q3 2015$12,895,000
+26.1%
687,0000.0%0.01%
+20.0%
Q2 2015$10,229,000
-1.7%
687,0000.0%0.01%0.0%
Q1 2015$10,405,000
+13.7%
687,0000.0%0.01%
+25.0%
Q4 2014$9,151,000
+5.6%
687,0000.0%0.00%0.0%
Q3 2014$8,663,000
+24.8%
687,0000.0%0.00%
+33.3%
Q2 2014$6,939,000
-24.9%
687,0000.0%0.00%
-25.0%
Q1 2014$9,240,000687,0000.00%
Other shareholders
CONCERT PHARMACEUTICALS INC shareholders Q2 2016
NameSharesValueWeighting ↓
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 2,610$620,000,0006.47%
Parkman Healthcare Partners LLC 1,124,072$4,732,0001.74%
Kynam Capital Management, LP 1,000,000$4,210,0001.08%
EAM Investors, LLC 850,647$3,581,0000.87%
BVF INC/IL 3,629,000$15,278,0000.74%
EAM Global Investors LLC 388,730$1,637,0000.40%
RA Capital Management 3,307,203$13,923,0000.37%
Nantahala Capital Management 1,659,840$6,988,0000.35%
AWM Investment Company, Inc. 504,661$2,125,0000.34%
INGALLS & SNYDER LLC 1,411,153$5,941,0000.31%
View complete list of CONCERT PHARMACEUTICALS INC shareholders